Search

everythinglearnresearchcommunity

for

Search:↓

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Vitiligo causes white skin patches and is linked to autoimmune issues.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Psoriasis can cause temporary or permanent hair loss.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Dermoscopy now helps diagnose various skin, hair, and nail issues, improving patient care and treatment understanding.

Stress hormones like cortisol may trigger psoriasis flare-ups.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

The document concludes that syphilis has varied symptoms that are often missed, making clinical awareness crucial for diagnosis.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

The document concludes that changing the scalp's microbiome might be a new way to treat hair loss.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Compounded topical preparations should be used with caution for severe psoriasis and generally come after systemic treatments.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

FUE hair transplants are generally safe but require careful planning to avoid rare complications.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

The microbiome may be linked to hair loss and could be a target for new treatments.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

The letters discussed medical tools, costs, treatment efficacy, and patient care complexities.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.